Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2018-11-02 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share capital changes during the month. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, not a full annual or interim report, nor an earnings release or management discussion. This type of document fits best under 'Major Shareholding Notification' (MRQ) or 'Share Issue/Capital Change' (SHA). Since it details movements in share capital including share options and warrants, it aligns more closely with 'Share Issue/Capital Change' (SHA). The document length is substantial and contains detailed data on share capital changes, not just an announcement or summary, so it is not an RPA or RNS. Therefore, the correct classification is SHA with high confidence.
2018-11-02 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return (Equity issuer - changes in issued share capital and/or share buybacks)' and details changes in issued share capital and share repurchases for PW Medtech Group Limited. It includes specific data on share issues, exercise of share options, and confirms compliance with listing rules regarding share repurchases. The content focuses on disclosure of share capital changes and buybacks, which aligns with announcements about share issues or capital changes rather than a full financial report or other categories. The document length is 6148 characters, which is sufficient for a detailed disclosure rather than a brief announcement. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA).
2018-10-26 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2018
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes during the month. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, not a full financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a compliance document reporting share capital movements to the exchange.
2018-10-03 English
CLOSING UNDER THE SHARE PURCHASE AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the closing of a share purchase agreement and acquisition of shares in another company (CBPO). It references a previous announcement and details the completion of conditions precedent to the closing. The content focuses on a transaction related to share acquisition and ownership percentage. There are no financial statements, earnings data, or detailed financial analysis present. The document is short (1628 characters) and serves as an update on a financing/capital transaction rather than a full report or regulatory filing. Therefore, it fits best under Capital/Financing Update (CAP).
2018-09-24 English
ANNOUNCEMENT IN RELATION TO RULE 13.18 OF THE LISTING RULES
Capital/Financing Update Classification · 95% confidence The document is an announcement related to Rule 13.18 of the Listing Rules of The Stock Exchange of Hong Kong Limited. It details a loan agreement entered into by the company, including terms about mandatory prepayment triggered by changes in controlling shareholder ownership. The content focuses on financing arrangements and loan terms rather than financial results, management changes, or regulatory certifications. The document length is 2774 characters, which is relatively short and is a direct announcement of a financing-related event. Therefore, it fits best under Capital/Financing Update (CAP).
2018-09-21 English
Interim Report 2018
Interim / Quarterly Report Classification · 95% confidence The document is titled '2018 INTERIM REPORT' and contains detailed sections such as 'Management Discussion and Analysis', 'Business and Market Review', 'Business Strategies and Future Outlook', and 'Financial Review'. It covers the six months ended June 30, 2018, which is a period shorter than a full fiscal year. The content includes substantive financial data, business trends, and outlook, consistent with an interim or quarterly report. The document length is substantial (15,000 characters), indicating it is the report itself rather than an announcement of a report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2018
2018-09-20 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.